Russell Angus C.
- SEC CIK
- 0001534002
No open-market purchases or sales filed in the past year.
Current role at each company
- LCTX Lineage Cell Therapeutics, Inc.Directoras of Jul 2, 2026
- GPCR Structure Therapeutics Inc.Directoras of Jun 18, 2026
- RVNC Revance Therapeutics, Inc.Directoras of Feb 6, 2025
- TXMD TherapeuticsMD, Inc.Directoras of Oct 3, 2022
- MNKTQ Keenova Therapeutics plcDirectoras of Jun 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Russell Angus C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RVNC Revance Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 (view filing) | Dec 13 | 2 days | Russell Angus C.Director | PPurchase | +6.40K | $15.74 | +$100.7K | +31.2%26.9K after |